Current and historical daily PE Ratio for Reshape Lifesciences Inc (
STU:24O0
) from 2021 to Jun 04 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Reshape Lifesciences stock (STU:24O0) PE ratio as of Jun 04 2024 is 0.
More Details
Reshape Lifesciences Inc (STU:24O0) PE Ratio (TTM) Chart
Reshape Lifesciences Inc (STU:24O0) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 727
- 1
- 2
- 3
- 4
- 5
- 6
- 9
| Reshape Lifesciences PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-04 | At Loss | 2024-01-30 | At Loss |
| 2024-04-02 | At Loss | 2024-01-29 | At Loss |
| 2024-03-29 | At Loss | 2024-01-26 | At Loss |
| 2024-03-28 | At Loss | 2024-01-25 | At Loss |
| 2024-03-27 | At Loss | 2024-01-24 | At Loss |
| 2024-03-26 | At Loss | 2024-01-23 | At Loss |
| 2024-03-25 | At Loss | 2024-01-22 | At Loss |
| 2024-03-22 | At Loss | 2024-01-19 | At Loss |
| 2024-03-21 | At Loss | 2024-01-18 | At Loss |
| 2024-03-20 | At Loss | 2024-01-17 | At Loss |
| 2024-03-19 | At Loss | 2024-01-16 | At Loss |
| 2024-03-18 | At Loss | 2024-01-15 | At Loss |
| 2024-03-15 | At Loss | 2024-01-12 | At Loss |
| 2024-03-14 | At Loss | 2024-01-11 | At Loss |
| 2024-03-13 | At Loss | 2024-01-10 | At Loss |
| 2024-03-12 | At Loss | 2024-01-09 | At Loss |
| 2024-03-11 | At Loss | 2024-01-08 | At Loss |
| 2024-03-08 | At Loss | 2024-01-05 | At Loss |
| 2024-03-07 | At Loss | 2024-01-04 | At Loss |
| 2024-03-06 | At Loss | 2024-01-03 | At Loss |
| 2024-03-05 | At Loss | 2024-01-02 | At Loss |
| 2024-03-04 | At Loss | 2024-01-01 | At Loss |
| 2024-03-01 | At Loss | 2023-12-29 | At Loss |
| 2024-02-29 | At Loss | 2023-12-28 | At Loss |
| 2024-02-28 | At Loss | 2023-12-27 | At Loss |
| 2024-02-27 | At Loss | 2023-12-25 | At Loss |
| 2024-02-26 | At Loss | 2023-12-22 | At Loss |
| 2024-02-23 | At Loss | 2023-12-21 | At Loss |
| 2024-02-22 | At Loss | 2023-12-20 | At Loss |
| 2024-02-21 | At Loss | 2023-12-19 | At Loss |
| 2024-02-20 | At Loss | 2023-12-18 | At Loss |
| 2024-02-19 | At Loss | 2023-12-15 | At Loss |
| 2024-02-16 | At Loss | 2023-12-14 | At Loss |
| 2024-02-15 | At Loss | 2023-12-13 | At Loss |
| 2024-02-14 | At Loss | 2023-12-12 | At Loss |
| 2024-02-13 | At Loss | 2023-12-11 | At Loss |
| 2024-02-12 | At Loss | 2023-12-08 | At Loss |
| 2024-02-09 | At Loss | 2023-12-07 | At Loss |
| 2024-02-08 | At Loss | 2023-12-06 | At Loss |
| 2024-02-07 | At Loss | 2023-12-05 | At Loss |
| 2024-02-06 | At Loss | 2023-12-04 | At Loss |
| 2024-02-05 | At Loss | 2023-12-01 | At Loss |
| 2024-02-02 | At Loss | 2023-11-30 | At Loss |
| 2024-02-01 | At Loss | 2023-11-29 | At Loss |
| 2024-01-31 | At Loss | 2023-11-28 | At Loss |
Reshape Lifesciences Inc (STU:24O0) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Reshape Lifesciences Inc
NAICS : 334510
SIC : 3845
ISIN : US76090R2004
Description
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers